Navellier & Associates Inc. Sells 451 Shares of Axon Enterprise, Inc (NASDAQ:AXON)

Navellier & Associates Inc. trimmed its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 3.1% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 14,101 shares of the biotechnology company's stock after selling 451 shares during the period. Axon Enterprise comprises approximately 1.1% of Navellier & Associates Inc.'s investment portfolio, making the stock its 16th biggest position. Navellier & Associates Inc.'s holdings in Axon Enterprise were worth $7,416,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Fourth Dimension Wealth LLC acquired a new position in Axon Enterprise in the 4th quarter worth approximately $30,000. Bartlett & CO. Wealth Management LLC boosted its stake in Axon Enterprise by 132.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock worth $31,000 after purchasing an additional 33 shares during the period. Catalyst Capital Advisors LLC acquired a new position in Axon Enterprise in the 1st quarter worth approximately $32,000. Alpine Bank Wealth Management acquired a new stake in shares of Axon Enterprise during the 1st quarter valued at $40,000. Finally, Elequin Capital LP acquired a new stake in shares of Axon Enterprise during the 4th quarter valued at $46,000. 79.08% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on AXON shares. JMP Securities lifted their target price on shares of Axon Enterprise from $725.00 to $825.00 and gave the company a "market outperform" rating in a research note on Tuesday. JPMorgan Chase & Co. lifted their target price on shares of Axon Enterprise from $730.00 to $850.00 and gave the company an "overweight" rating in a research note on Thursday, July 17th. Morgan Stanley set a $885.00 target price on shares of Axon Enterprise and gave the company an "overweight" rating in a research note on Friday, July 11th. The Goldman Sachs Group lifted their target price on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research note on Wednesday, May 14th. Finally, Barclays raised their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a report on Friday, May 9th. One analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $772.08.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, CAO Jennifer H. Mak sold 75 shares of the company's stock in a transaction that occurred on Friday, June 13th. The shares were sold at an average price of $771.81, for a total value of $57,885.75. Following the completion of the sale, the chief accounting officer owned 15,240 shares of the company's stock, valued at approximately $11,762,384.40. This represents a 0.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Joshua Isner sold 905 shares of the company's stock in a transaction that occurred on Tuesday, June 17th. The shares were sold at an average price of $776.39, for a total transaction of $702,632.95. Following the completion of the sale, the president directly owned 268,735 shares of the company's stock, valued at $208,643,166.65. The trade was a 0.34% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 34,642 shares of company stock valued at $25,090,528. Corporate insiders own 4.40% of the company's stock.

Axon Enterprise Trading Up 3.6%

Shares of AXON traded up $25.75 on Friday, reaching $735.01. 654,601 shares of the company's stock were exchanged, compared to its average volume of 627,317. The company has a current ratio of 2.83, a quick ratio of 2.62 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $57.22 billion, a P/E ratio of 177.54, a price-to-earnings-growth ratio of 79.06 and a beta of 1.29. The business has a 50 day moving average price of $763.82 and a two-hundred day moving average price of $650.42. Axon Enterprise, Inc has a 12 month low of $279.02 and a 12 month high of $830.21.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The business had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. During the same period in the previous year, the firm posted $1.15 earnings per share. Axon Enterprise's revenue for the quarter was up 31.3% compared to the same quarter last year. Research analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.